Vivos TherapeuticsVVOS
13F holders, Q3 2025 (September 30)23holders +4
7new positions
3sold out
1famous investor
$3.10avg. 13F price*
At the end of Q3 2025, 23 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings, up 4 from Q2 2025. 7 opened new positions and 3 sold out. The largest holders were Connective Capital Management, LLC ($620K), Strategic Wealth Investment Group, LLC ($310K) and Vanguard Group Inc. ($284K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.3M |
| Exits | 3 | $65K |
All 13F filers, Q2 2025 → Q3 2025: 478,587 shares bought and 193,942 shares sold, net +284,645 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Connective Capital Management, LLC | 0.57% | New | 200,000 | $620K |
| Strategic Wealth Investment Group, LLC | 0.03% | New | 100,000 | $310K |
| Vanguard Group Inc. | 0.00% | Add +114.5% | 91,461 | $284K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.0% | 53,289 | $165K |
| B. Riley Wealth Advisors, Inc. | 0.01% | Reduce -37.4% | 43,531 | $135K |
| DRW Securities, LLC | 0.01% | New | 41,466 | $129K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 41,000 | $127K |
| Renaissance Technologies | 0.00% | New | 39,279 | $122K |
| BlackRock, Inc. | 0.00% | New | 27,817 | $86K |
| State Street Corp. | 0.00% | Add +110.8% | 24,922 | $77K |
| Northern Trust Corp. | 0.00% | No change | 12,511 | $39K |
| Osaic Holdings, Inc. | 0.00% | Add +726.4% | 6,553 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +462.2% | 2,794 | $9K |
| Morgan Stanley | 0.00% | No change | 1,065 | $3K |
| Signaturefd, LLC | 0.00% | No change | 547 | $2K |
| Blue Trust, Inc. | 0.00% | No change | 160 | $496 |
| Bank of America Corp. | 0.00% | Reduce -14.6% | 117 | $363 |
| UBS Group AG | 0.00% | Reduce -99.9% | 102 | $316 |
| FMR LLC | 0.00% | New | 40 | $124 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $117 |
| Global Retirement Partners, LLC | 0.00% | No change | 23 | $71 |
| Citigroup Inc. | 0.00% | New | 1 | $3 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.